OA12648A - Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. - Google Patents
Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. Download PDFInfo
- Publication number
- OA12648A OA12648A OA1200400033A OA1200400033A OA12648A OA 12648 A OA12648 A OA 12648A OA 1200400033 A OA1200400033 A OA 1200400033A OA 1200400033 A OA1200400033 A OA 1200400033A OA 12648 A OA12648 A OA 12648A
- Authority
- OA
- OAPI
- Prior art keywords
- lercanidipine
- hydrochloride
- lercanidipine hydrochloride
- crude
- solid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI001726A ITMI20011726A1 (it) | 2001-08-06 | 2001-08-06 | Forme polimorfe della lercanidipina cloridrato |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12648A true OA12648A (en) | 2006-06-16 |
Family
ID=11448245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200400033A OA12648A (en) | 2001-08-06 | 2002-08-05 | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. |
Country Status (36)
| Country | Link |
|---|---|
| EP (4) | EP2157083B1 (da) |
| JP (1) | JP2005504045A (da) |
| KR (3) | KR100667687B1 (da) |
| CN (2) | CN100448847C (da) |
| AP (1) | AP1766A (da) |
| AR (1) | AR037139A1 (da) |
| AT (2) | ATE307114T1 (da) |
| AU (1) | AU2002327924C1 (da) |
| BR (1) | BR0211739A (da) |
| CY (2) | CY1109711T1 (da) |
| DE (2) | DE60234961D1 (da) |
| DK (3) | DK1600441T3 (da) |
| EA (1) | EA005673B1 (da) |
| EC (1) | ECSP044973A (da) |
| ES (3) | ES2334678T3 (da) |
| HK (3) | HK1067123A1 (da) |
| HR (1) | HRP20040156B1 (da) |
| HU (1) | HU229563B1 (da) |
| IL (3) | IL153917A (da) |
| IT (1) | ITMI20011726A1 (da) |
| MA (1) | MA27133A1 (da) |
| ME (2) | ME01525B (da) |
| MX (1) | MXPA04001069A (da) |
| NO (2) | NO325541B1 (da) |
| NZ (2) | NZ541341A (da) |
| OA (1) | OA12648A (da) |
| PE (1) | PE20030328A1 (da) |
| PL (1) | PL216066B1 (da) |
| PT (2) | PT2157083E (da) |
| RS (1) | RS52161B (da) |
| SI (3) | SI1600441T1 (da) |
| TN (1) | TNSN04024A1 (da) |
| UA (1) | UA82988C2 (da) |
| UY (1) | UY27410A1 (da) |
| WO (1) | WO2003014084A1 (da) |
| ZA (1) | ZA200401806B (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20011726A1 (it) | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| AR043395A1 (es) * | 2003-02-28 | 2005-07-27 | Recordati Ireland Ltd | Terapia de combinacion para la hipertension utilizando lercanidipina y un bloqueante de los receptores de angiotensina ii |
| JP2007512265A (ja) * | 2003-12-01 | 2007-05-17 | ライフサイクル ファーマ アクティーゼルスカブ | レルカニジピンを含む医薬組成物 |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| KR20080048065A (ko) | 2005-09-16 | 2008-05-30 | 그렌마크 파머수티칼스 엘티디. | 다형 형태의 염산 레르카니디핀 및 이것의 제조방법 |
| KR100821165B1 (ko) * | 2006-03-10 | 2008-04-14 | 동우신테크 주식회사 | 레르카니디핀 염산염의 제조 방법 |
| WO2008082041A1 (en) * | 2006-12-29 | 2008-07-10 | Dongwoo Syntech Co., Ltd | Process for preparing lercanidipine hydrochloride |
| WO2008107797A2 (en) * | 2007-03-05 | 2008-09-12 | Actavis Group Ptc Ehf | Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate |
| WO2011161223A2 (en) | 2010-06-23 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
| EP2444394A1 (en) | 2010-10-21 | 2012-04-25 | Alembic Pharmaceuticals Limited | Process for the preparation of amorphous form of lercanidipine HCI |
| SI2654729T1 (sl) | 2010-12-24 | 2016-08-31 | Krka, D.D., Novo Mesto | Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino |
| JP2014511867A (ja) * | 2011-04-18 | 2014-05-19 | 合肥貝霓医薬科技有限公司 | ジヒドロピリジン系カルシウムチャネルブロッカーの精製、及びそのナノ粒子の調製方法 |
| CN102531999B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 无定形盐酸乐卡地平及其制备方法 |
| CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
| CN102584682A (zh) * | 2011-12-31 | 2012-07-18 | 苏州二叶制药有限公司 | 盐酸乐卡地平的制备方法 |
| CN103497075B (zh) * | 2013-09-25 | 2016-03-23 | 山西北化关铝化工有限公司 | 水悬浮延期药造型粉 |
| CN109232389B (zh) * | 2018-05-15 | 2021-10-08 | 迪嘉药业集团有限公司 | 一种小粒度硝苯地平的结晶制备方法 |
| CN115353485B (zh) * | 2022-07-26 | 2024-04-19 | 山西双雁药业有限公司 | 从硝苯地平母液中回收硝苯地平的方法及应用 |
| CN115671066B (zh) * | 2022-11-21 | 2024-07-02 | 安徽宏业药业有限公司 | 一种盐酸乐卡地平片及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US596139A (en) * | 1897-12-28 | Process of generating acetylene gas | ||
| GB8403866D0 (en) | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
| US5696139A (en) * | 1995-05-12 | 1997-12-09 | Recordati S.A., Chemical And Pharmaceutical Company | Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure |
| IT1274480B (it) * | 1995-05-12 | 1997-07-17 | Recordati Chem Pharm | Procedimento migliorato per la preparazione della lercanidipina cloridrato |
| US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
| IT1275532B (it) * | 1995-07-14 | 1997-08-07 | Recordati Chem Pharm | Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa |
| EE200200453A (et) | 2000-02-16 | 2003-12-15 | Neurogen Corporation | Asendatud arüülpürasiinid |
| ITMI20011726A1 (it) | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| US20040198789A1 (en) | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
-
2001
- 2001-08-06 IT IT2001MI001726A patent/ITMI20011726A1/it unknown
-
2002
- 2002-05-08 UA UA2004031657A patent/UA82988C2/uk unknown
- 2002-08-02 AR ARP020102958A patent/AR037139A1/es unknown
- 2002-08-05 JP JP2003519034A patent/JP2005504045A/ja active Pending
- 2002-08-05 SI SI200230871T patent/SI1600441T1/sl unknown
- 2002-08-05 AP APAP/P/2004/002989A patent/AP1766A/en active
- 2002-08-05 DK DK05106264.4T patent/DK1600441T3/da active
- 2002-08-05 EP EP09174609.9A patent/EP2157083B1/en not_active Expired - Lifetime
- 2002-08-05 AU AU2002327924A patent/AU2002327924C1/en not_active Expired
- 2002-08-05 RS YU11304A patent/RS52161B/en unknown
- 2002-08-05 BR BR0211739-8A patent/BR0211739A/pt not_active Application Discontinuation
- 2002-08-05 EA EA200400280A patent/EA005673B1/ru unknown
- 2002-08-05 IL IL15391702A patent/IL153917A/xx active IP Right Grant
- 2002-08-05 AT AT02762428T patent/ATE307114T1/de active
- 2002-08-05 DE DE60234961T patent/DE60234961D1/de not_active Expired - Lifetime
- 2002-08-05 OA OA1200400033A patent/OA12648A/en unknown
- 2002-08-05 EP EP02762428A patent/EP1432683B9/en not_active Expired - Lifetime
- 2002-08-05 ME MEP-2008-29A patent/ME01525B/me unknown
- 2002-08-05 DK DK09174609.9T patent/DK2157083T3/da active
- 2002-08-05 KR KR1020047001558A patent/KR100667687B1/ko not_active IP Right Cessation
- 2002-08-05 NZ NZ541341A patent/NZ541341A/en not_active IP Right Cessation
- 2002-08-05 CN CNB028154134A patent/CN100448847C/zh not_active Expired - Lifetime
- 2002-08-05 SI SI200230250T patent/SI1432683T1/sl unknown
- 2002-08-05 WO PCT/EP2002/008699 patent/WO2003014084A1/en active IP Right Grant
- 2002-08-05 KR KR1020057021508A patent/KR100626819B1/ko not_active IP Right Cessation
- 2002-08-05 PT PT91746099T patent/PT2157083E/pt unknown
- 2002-08-05 AT AT05106264T patent/ATE453624T1/de active
- 2002-08-05 IL IL16464802A patent/IL164648A0/xx active IP Right Grant
- 2002-08-05 DK DK02762428T patent/DK1432683T3/da active
- 2002-08-05 EP EP05106264A patent/EP1600441B1/en not_active Expired - Lifetime
- 2002-08-05 CN CN2008101812364A patent/CN101475524B/zh not_active Expired - Lifetime
- 2002-08-05 EP EP08019093A patent/EP2036890A1/en not_active Withdrawn
- 2002-08-05 DE DE60206787T patent/DE60206787T2/de not_active Expired - Lifetime
- 2002-08-05 SI SI200231065T patent/SI2157083T1/sl unknown
- 2002-08-05 HU HU0401163A patent/HU229563B1/hu unknown
- 2002-08-05 NZ NZ531558A patent/NZ531558A/en not_active IP Right Cessation
- 2002-08-05 ES ES05106264T patent/ES2334678T3/es not_active Expired - Lifetime
- 2002-08-05 ME MEP-29/08A patent/MEP2908A/xx unknown
- 2002-08-05 PL PL369522A patent/PL216066B1/pl unknown
- 2002-08-05 ES ES02762428T patent/ES2212759T3/es not_active Expired - Lifetime
- 2002-08-05 KR KR1020057006786A patent/KR20050043992A/ko not_active Application Discontinuation
- 2002-08-05 ES ES09174609.9T patent/ES2555213T3/es not_active Expired - Lifetime
- 2002-08-05 MX MXPA04001069A patent/MXPA04001069A/es active IP Right Grant
- 2002-08-05 PT PT05106264T patent/PT1600441E/pt unknown
- 2002-08-06 PE PE2002000715A patent/PE20030328A1/es not_active Application Discontinuation
- 2002-08-06 UY UY27410A patent/UY27410A1/es unknown
-
2004
- 2004-01-20 NO NO20040266A patent/NO325541B1/no not_active IP Right Cessation
- 2004-02-05 TN TNP2004000024A patent/TNSN04024A1/en unknown
- 2004-02-06 MA MA27517A patent/MA27133A1/fr unknown
- 2004-02-06 EC EC2004004973A patent/ECSP044973A/es unknown
- 2004-02-18 HR HR20040156A patent/HRP20040156B1/xx not_active IP Right Cessation
- 2004-03-04 ZA ZA2004/01806A patent/ZA200401806B/en unknown
- 2004-10-17 IL IL164648A patent/IL164648A/en not_active IP Right Cessation
- 2004-12-23 HK HK04110181A patent/HK1067123A1/xx not_active IP Right Cessation
-
2006
- 2006-05-29 HK HK06106196.3A patent/HK1086263A1/xx not_active IP Right Cessation
- 2006-05-29 HK HK10106911.1A patent/HK1140487A1/xx not_active IP Right Cessation
-
2008
- 2008-05-22 NO NO20082330A patent/NO335651B1/no not_active IP Right Cessation
-
2010
- 2010-01-05 CY CY20101100011T patent/CY1109711T1/el unknown
-
2015
- 2015-12-10 CY CY20151101129T patent/CY1117051T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050192323A1 (en) | Novel crude and crystalline forms of lercanidipine hydrochloride | |
| OA12648A (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. | |
| EP1799644B1 (en) | Lercanidipine salts | |
| AU2002327924A1 (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation | |
| US20030069285A1 (en) | Novel solvate and crystalline forms of lercanidipine hydrochloride | |
| KR100912664B1 (ko) | 레르카니디핀 염산의 용매화물 및 레르카니디핀 염산의신규 결정형 | |
| AU2002331390A1 (en) | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride | |
| CA2399459C (en) | Novel crude and crystalline forms of lercanidipine hydrochloride | |
| CA2380202A1 (en) | Novel crude and crystalline forms of lercanidipine hydrochloride |